Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 6,090
- Estimated value
- Report date
- 21 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount